| Effects of altered endocrine function on biliary metabolites of [4-14C]androst-4-ene-3,17-dione in rats. Possible utility as a model for identifying anti-atherosclerotic agents. | |
| | |
MedLine Citation:
|
PMID: 3994776 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Atherosclerosis, coronary artery disease and elevated serum cholesterol are frequently associated with an abnormal pattern of androgen metabolites, especially an elevation of etiocholanolone (E) and/or epiandrosterone (EA) relative to androsterone (A). Therapeutic correction of these metabolic defects may lower serum cholesterol. We have attempted to reproduce this metabolic syndrome in rats by altering their endocrine status. Intact male rats excreted very little A or E in their bile; more than 80% of the [4-14C]A-dione was excreted as unknown polar compounds. Adrenalectomy, thyroidectomy or streptozotocin diabetes induced little or no change in the excretion of both E and A and did not alter the A/E ratio. Hypophysectomy (hypox), however, resulted in a huge increase in E excretion and a 10-fold decrease in the A/E ratio. Treatment of hypophysectomized males with bovine growth hormone (bGH) but not testosterone or thyroxine restored the pattern of androgen metabolites to that of intact male rats. Intact female rats excreted mainly A, and this was decreased by ovariectomy. Hypophysectomy, however, resulted in a marked increase in E and a corresponding large decrease in A excretion. Treatment of hypox females with estradiol or triiodothyronine did not correct the metabolic defects in A and E production, whereas GH resulted in a pattern of A-dione metabolism resembling that of intact males; i.e., primarily polar metabolites with low A and E. Hypophysectomy thus results in a dramatic increase in 5 beta-reductase activity in male and female rats. GH therapy restores the metabolic pathway to that seen in intact males. Our objective had been to find a model capable of detecting substances which would increase A and decrease E production. The male rat (regardless of endocrine status) has little 5 alpha-reductase activity. The intact female rat, however, has high 5 alpha-reductase activity, and retains significant 5 alpha-reductase in the absence of the ovaries. In hypox females, 5 alpha-reductase was much reduced while 5 beta-reductase was increased. Furthermore, serum cholesterol was elevated in hypox females but could be lowered by exogenous androsterone. Thus the hypox female rat appears to offer the best model for identifying non-hormonal agents which could enhance the production of A and/or decrease the production of E. Such agents might favorably influence cholesterol metabolism. |
| | |
Authors:
|
B G Steinetz; M Phillipps; M J Wasvary; H V Kothari; W K Sawyer; R E Steele |
Related Documents
:
|
3186336 - Sexual differentiation of rat hepatic bile salt sulfotransferase isoenzymes. 18582496 - Female gonadal hormones, mild restraint, and male preference. 11359696 - Fumonisin b1 carcinogenicity in a two-year feeding study using f344 rats and b6c3f1 mice. 6886376 - Male urinary protein-1 (mup-1) expression in the female rat. 3393076 - Rat surgery board. 15869936 - Structural and functional alterations of spinal cord axons in adult long evans shaker (... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Atherosclerosis Volume: 54 ISSN: 0021-9150 ISO Abbreviation: Atherosclerosis Publication Date: 1985 Jan |
Date Detail:
|
Created Date: 1985-06-06 Completed Date: 1985-06-06 Revised Date: 2003-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0242543 Medline TA: Atherosclerosis Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 11-21 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Androstenedione
/
metabolism* Androsterone / metabolism Animals Arteriosclerosis / metabolism* Bile / metabolism* Castration Etiocholanolone / metabolism Female Growth Hormone / pharmacology Hypophysectomy Male Models, Biological Rats Rats, Inbred Strains |
| Chemical | |
Reg. No./Substance:
|
53-41-8/Androsterone; 53-42-9/Etiocholanolone; 63-05-8/Androstenedione; 9002-72-6/Growth Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of removal of atherogenic diet on protein synthesis and cholesterol retention in rabbit aorta...
Next Document: Serum linoleic acid and cardiovascular death in postinfarction middle-aged men.